Normalized Fat-Ratio Diagnosis for Partial Lipodystrophy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for diagnosing partial lipodystrophy lack sufficient specificity and sensitivity, leading to delayed or misdiagnosis due to phenotypic heterogeneity and genetic complexity, and existing algorithms do not adequately account for fat distribution patterns.

Innovation Solution

A diagnostic method using trunk/leg fat percent ratios normalized to total body fat percentage, with specific thresholds for different demographics, and a decision tree algorithm for females, to accurately identify partial lipodystrophy, optionally followed by treatment with LEPR agonists.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional diagnostic methods are used for partial lipodystrophy, then the diagnostic process is simple, but the sensitivity and specificity are insufficient leading to delayed or misdiagnosis

Engineering Contradiction:
Improvediagnostic accuracyVSAvoiddiagnostic algorithm complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent transforms the diagnostic approach by changing from simple visual assessment to quantitative measurement of fat distribution parameters (trunk/leg ratio, total body fat percentage). These parameter changes enable precise mathematical thresholds to be established, dramatically improving diagnostic accuracy while maintaining operational simplicity through automated calculations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces a new dimensional approach by using ratios and normalized values (trunk/leg fat ratio, percentage of total body fat) rather than absolute measurements. This dimensional transformation allows the diagnostic criteria to be scaled and applied across different body types and demographics, improving both accuracy and generalizability.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If static trunk/leg fat ratio thresholds are used, then the diagnostic criteria are simple, but they do not account for variations in total body fat percentage leading to reduced accuracy

Engineering Contradiction:
Improvediagnostic accuracyVSAvoiddiagnostic application simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent normalizes the trunk/leg ratio by expressing it as a percentage of total body fat rather than using absolute ratios. This parameter transformation accounts for individual variations in total body composition, allowing the same diagnostic threshold to accurately identify partial lipodystrophy across different body types while maintaining mathematical simplicity.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If demographic-specific thresholds are established, then the diagnostic accuracy is improved, but the diagnostic protocol becomes more complex

Engineering Contradiction:
Improvediagnostic accuracyVSAvoiddiagnostic protocol complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies different diagnostic thresholds tailored to specific demographic groups (sex, ethnicity, age). This local customization of diagnostic criteria optimizes accuracy for each population while maintaining a unified mathematical framework. The complexity is managed through clear demographic classification followed by application of the appropriate threshold set.

Inventive Principle:
Principle #3Local quality

Data Source

PatentEP4294257B1Method for diagnosing and treating partial lipodystrophy
Publication Date: 2025.11.05 REGENERON PHARMACEUTICALS INC
  • EP4294257B1 patent drawingFigure 1
  • EP4294257B1 patent drawingFigure 2
  • EP4294257B1 patent drawingFigure 3

AI summary

The present invention provides highly specific and selective methods for diagnosing partial lipodystrophy (e.g., familial partial lipodystrophy) in a subject. Methods for treating partial lipodystrophy are also provided.